Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.78 +0.22 (+0.30%)
As of: Oct 20, 2026 · 1:11 PM EDT

Ani Pharmaceuticals (ANIP) Non-Current Assets (2010 - 2026)

Updated

Ani Pharmaceuticals' Non-Current Assets was $668.68 million in Q2 2026, down 9.7% from $740.37 million a year earlier and down 0.9% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Ani Pharmaceuticals came in at $687.26 million, down 9.1% from FY2024.

  • Non-Current Assets shows a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
  • In earlier years, Non-Current Assets was $756.01 million in FY2024 (+96.6%), $384.61 million in FY2023 (-7.5%), $415.83 million in FY2022 (-7.6%) and $449.82 million in FY2021 (+54.6%).
  • The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q2 2024.
  • Compared with a year earlier, Non-Current Assets has declined for four straight quarters, with growth averaging 45.0% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Assets over five years was Q2 2025 (growth of 102.7%); the worst was Q1 2026 (a decline of 10.7%).
  • Per Business Quant data, ANIP's Non-Current Assets in the three quarters before Q2 2026 was $674.89 million (Q1 2026), $687.26 million (Q4 2025) and $709.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,154.54 Bn 1,123.13 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 623.94 Bn 542.46 Bn 17.26 Bn 141.29 Bn
3 AbbVie 511.93 Bn 485.04 Bn 12.70 Bn 101.45 Bn
4 Merck 365.40 Bn 319.78 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.27 Bn 261.26 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn 87.87 Bn
7 Amgen 234.77 Bn 190.17 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 192.76 Bn 166.96 Bn 6.22 Bn 35.42 Bn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn 159.77 Bn
10 Ani Pharmaceuticals 1.54 Bn 320.19 Mn 165.89 Mn 668.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 668.68 Mn
Mar 31, 2026 674.89 Mn
Dec 31, 2025 687.26 Mn
Sep 30, 2025 709.75 Mn
Jun 30, 2025 740.37 Mn
Mar 31, 2025 756.14 Mn
Dec 31, 2024 756.01 Mn
Sep 30, 2024 766.08 Mn
Jun 30, 2024 365.29 Mn
Mar 31, 2024 373.97 Mn
Dec 31, 2023 384.61 Mn
Sep 30, 2023 392.69 Mn
Jun 30, 2023 400.03 Mn
Mar 31, 2023 400.47 Mn
Dec 31, 2022 415.83 Mn
Sep 30, 2022 429.73 Mn
Jun 30, 2022 428.94 Mn
Mar 31, 2022 443.45 Mn
Dec 31, 2021 449.82 Mn
Sep 30, 2021 279.07 Mn
API Access

Ani Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANIP&period=max&api_key=YOUR_API_KEY